Ovarian Cancer Researchers Identify Biomarker Linked to Prognosis in Aggressive Disease Type

Mar 7, 2017

Ovarian cancer researchers have identified a protein biomarker expressed on the surface of tumour cells in high-grade serous ovarian cancer, the most common and lethal subtype of the disease.Ovarian serous adenocarcinomaOvarian serous adenocarcinoma (Image courtesy of User KGH via Wikimedia Commons)

The findings, featured on the cover of the March 7 issue of Cell Reports, show that patients with high levels of the biomarker, CD151, have a poor prognosis, says lead author and Postdoctoral Fellow Mauricio Medrano.

“Ovarian cancer is many diseases,” says Medrano. “By identifying CD151 and its underlying role in cancer cell survival, we hope to develop a therapy to target it. As a marker for poor prognosis, with further research, there is the potential to develop a clinical screening tool to help personalize cancer treatment for patients.”

Medrano, who is also a molecular biologist and research associate at Princess Margaret Cancer Centre, University Health Network (UHN) talks about the research here. The research was led by Robert Rottapel, Professor in the Departments of Medical Biophysics and Immunology and UHN senior scientist.

In lab experiments, the research team used cell lines derived from 40 patient tumour samples to identify that CD151 contributes to the survival of cells of high-grade serous ovarian cancer origin. The team further analysed tissue samples from a cohort of approximately 1,000 patients to establish the correlation of high levels of CD151 to poor prognosis.

“For the scientific community,” says Medrano, “our study provides a lot of new information about other possible targets, not only CD151, that could be important and can provide new ideas for how to target ovarian cancer.”

The research was supported by the Ontario Institute for Cancer Research, Ovarian Cancer Canada, the Canadian Ovarian Cancer Research Consortium’s biobank funded by the Terry Fox Research Institute, and The Princess Margaret Cancer Foundation.

Tweets

UofT Medicine
@uoftmedicine
Can an app replace an in-person post-op Dr’s visit? #UofTMed’s @DrJohnSemple says it can sometimes be a good option https://t.co/FfoZF6asIq
UofT Medicine
@uoftmedicine
Strep bacteria is very common, but can sometimes turn dangerous. Here’s what you need to know to protect yourself: https://t.co/aqZFbfPL5x
UofT Medicine
@uoftmedicine
#StemCells have a lot of potential uses, including treating spinal cord injuries, #UofT study finds https://t.co/8ke95lVrOb

Fulfilling our Potential

At the Faculty of Medicine, we're fulfilling our potential by producing the next generation of scientists, scholars and clinicians who will change the medical landscape through research and education.

Watch Now
Back to Top